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Abstract The serum response element (SRE) contributes to 
transcriptional repression of the c-fos proto-oncogene. We show 
that the transcription factor SRF is able to repress SRE-depend- 
ent transcription, apparently by sequestering a co-activator. Only 
the DNA-binding core region is required for this SRE-dependent 
repression. Furthermore the phosphorylation status at potential 
casein kinase II sites within an N-terminal repression domain 
affects SRE-independent transcription. SRF may thus pleiotrop- 
ically influence cellular transcription, representing a novel aspect 
of SRF function. 
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1. Introduction 
The transmission ofextracellular signals often ends in the cell 
nucleus with the rapid and transient transcriptional ctivation 
of immediate arly genes. One regulatory sequence mediating 
this transcriptional ctivation is the serum response lement 
(SRE), which contributes to transcriptional regulation of a 
variety of genes, including the c-fos proto-onocogene [1]. In 
addition, the c-fos SRE is critical for basal repression of c-fos 
transcription [2~,]. 
The first SRE-binding protein identified was the serum re- 
sponse factor (SRF), a ubiquitously expressed nuclear 
phosphoprotein capable of dimerization [5,6]. The c-fos SRE 
SRF complex has the potential to recruit ernary complex fac- 
tors which belong to the Ets transcription factor family [7,8]. 
Mitogen-activated protein kinases phosphorylate rnary com- 
plex factors, thereby enhancing their transactivation potential 
and thus leading to c-fos induction [9 11]. 
Functional analyses of SRF have indicated that it acts as a 
transcriptional ctivator in vitro [5]. The C-terminal region of 
SRF may be responsible for this transcriptional activation since 
it functions as a transactivation domain when fused to the 
DNA-binding domain of the yeast protein GAL4 [12,13]. Con- 
trarily, the N-terminus of SRF mediates repression of tran- 
scription in GAL4-SRF fusions [12]. In vitro studies revealed 
that the core region of SRF (amino acids 133-222) is sufficient 
for DNA binding, dimerization and ternary complex factor 
recruitment [14]. However, modulation of the DNA-binding 
properties of SRF can be achieved by phosphorylation i  the 
N-terminal region, where five phosphorylation sites have been 
mapped in vivo [15,16]. Additional sites might be 
phosphorylated in vivo in the C-terminal region of SRF [13,17]. 
Since an increase of SRF phosphorylation ccurs after growth 
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factor stimulation in some cell lines, induced phosphorylation 
of SRF might affect c-fos stimulation [6,18]. 
In this report, it is demonstrated that SRF can repress tran- 
scription in vivo both SRE-specifically and SRE-independ- 
ently. SRF could thereby contribute to c-Jbs down-regulation. 
Furthermore, SRF may interfere with the function of many 
other transcription factors by regulatory squelching. 
2. Materials and methods 
The coding sequence of human SRFcDNA was fused to an artificial 
Kozak sequence and cloned into SG-new, a derivative of pSG5 [19], 
thereby generating a eukaryotic expression plasmid (SG-SRF) directing 
the production of full-length SRF. CMV-SRF was generated by cloning 
human SRF cDNA into the eukaryotic expression vector pEV3S [20] 
such that the first 9 amino acids of SRF were replaced by the sequence 
MASWGSELPI. Truncated versions of SRF were constructed by clon- 
ing parts of the SRF coding sequence into the eukaryotic pEV expres- 
sion plasmids [20]. The C-terminal truncation AC9 was identical to 
CMV-SRF at its N-terminus, but displayed the following amino acids 
at its C-terminus (the last authentic SRF amino acid is numbered): 
E242ARAAGYLAS. N-terminal truncations possessed the following 
amino acids at their N-termini (the first authentic SRF amino acid is 
numbered): AN2 (MASWGSGYPG73) and AN4 (MASWGSGYPD- 
KLGH3). AN2/AC9 and zlN4/AC9 were composites of ,~C9 and either 
zlN2 or AN4. 
Transient ransfection of mouse fibroblast NIH 3T3 cells, induction 
of quiescent cells with 12-O-tetradecanoylphorbol 13-acetate (TPA), 
measurement of luciferase activity, and normalization ftransfections 
were performed as described [17]. Relative luciferase activity is given 
as the mean (+ S.D.) of at least three independent experiments. 
3. Results 
c-fos transcription is down-regulated to a low basal level in 
continuously growing NIH 3T3 cells [4]. Under these growth 
conditions we transfected an SRF expression plasrnid 
(SG-SRF) or its parental plasmid SG-new into NIH 3T3 cells 
and assessed their impact on transcription with a luciferase 
reporter construct driven by two c-fos SREs (SRE2-tk80-1uc) 
[10]. At the highest amount of expression plasmid used (3/tg), 
transcription from the SRE2-tk80-1uc reporter construct was 
approximately 2-fold repressed in the presence of SG-new (Fig. 
1A). This suggests that eukaryotic promoter elements within 
SG-new titrate general components of the transcriptional ma- 
chinery and thus lead to unspecific repression of transcription. 
Accordingly, transcription from the SRE-less reporter con- 
struct tk80-1uc [10] was also repressed 2-fold at 3/.tg of trans- 
fected SG-new (Fig. 1B). However, upon transfection of 3 ¢zg 
SG-SRF, transcription from the SRE2-tk80-1uc reporter was 
approximately 19-fold repressed (Fig. 1A). The difference in the 
repression between SG-SRF and SG-new, which is a factor of 
approximately 9, is SRF-specific. This SRF-mediated repres- 
sion was primarily SRE-dependent, since transcription from 
the SRE-less tkS0-1uc onstruct was nearly unaffected by over- 
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expression of SG-SRF when compared to SG-new (Fig. 1B). 
These results demonstrate hat over-expressed SRF is able to 
repress transcription via the c-fos SRE. 
Previously, it has been shown that SRF affects preinitiation 
complex formation by TFI ID in vitro [21]. Thus, we wondered 
whether SRF may also interfere in vivo with the function of 
TFIID, which consists of the TATA-box binding protein (TBP) 
and the TBP-associated factors (TAFs). Therefore the SG-TBP 
expression plasmid was co-transfected with either 1.5 #g SG- 
new or 1.5 #g SRF. Increasing amounts of TBP resulted in the 
repression of SRE-dependent transcription i the presence of 
1.5#g SG-new (Fig. 2A). This repression was not due to eukar- 
yotic promoter sequences within SG-TBP titrating general 
components of the transcriptional machinery, as suggested 
above for SG-new, since this type of unspecific repression only 
marginally increased above 1.5 #g of SG-new or SG-SRF (see 
Fig. 1). Rather, this effect was very likely due to the titration 
of TAFs by a surplus of TBP or of general transcription factors 
by a surplus of TFIID, which would deplete the TAF pool 
available to TATA-box bound TBP molecules or the pool of 
general transcription factors available to interact with TATA- 
box bound TFIID, respectively. Surprisingly, this squelching 
effect of TBP was not observable with the SRE2-tk80-1uc re- 
porter in the presence of 1.5 #g SG-SRF (Fig. 2A). These 
results uggest that exogenous SRF already sequesters a factor 
required for SRE-mediated transcription and therefore TBP 
over-expression would have no additional effect. This factor 
appears not to be TBP itself or another general transcription 
factor, since the solely TATA-box dependent transcription of 
the tk80-1uc reporter was comparably repressed by TBP over- 
expression in the presence of 1.5 #g SG-new and of 1.5 #g 
SG-SRF (Fig. 2B). Thus, the SRE-specific repression of tran- 
scription by over-expressed SRF is probably due to the seques- 
tration of a co-activator. 
Recently, a C-terminal transactivation and an N-terminal 
repression domain have been identified in fusion proteins of 
SRF and the yeast protein GAL4 [12,13]. The C-terminal 
transactivation domain has been localised to SRF amino acids 
406-476 [13] and the repression domain extends from amino 
acids 45-141 (R.J. and W.H.E., unpublished results). In order 
to investigate whether these domains mapped in artificial 
GAL4-SRF fusion proteins have a function in the context of 
the proper SRF molecule, we constructed several mutations 
(Fig. 3A). All of these molecules can bind to the c-fos SRE by 
virtue of the core region, and their expression was confirmed 
and quantified in comparative t rms by gel retardation assays 
(data not shown). Once again, SRF repressed SRE-driven tran- 
scription whereas transcription from the tkS0-1uc reporter con- 
struct was nearly unaffected (compare pEV3S to CMV-SRF in 
Fig. 3B). Deletion of the C-terminal transactivation domain in 
AC9 did not abolish the repression of SRE-driven transcription, 
but rather led to a 2-fold higher degree of SRE-dependent 
repression relative to CMV-SRF without affecting transcrip- 
tion from the tk80-1uc reporter. In contrast, the N-terminal 
truncations AN2 and AN4 behaved as CMV-SRF. Similarly, the 
/IN2 and AN4 mutants did not significantly differ from CMV- 
SRF in their ability to stimulate SRE-dependent transcription 
upon TPA treatment of starved cells, whereas the loss of the 
transactivation domain in AC9 did cause a significant reduction 
(Fig. 3C). Thus, the N-terminal repression domain seemingly 
does not affect SRF's transcriptional competence, while the 
C-terminal transactivation domain contributes to both basal 
and TPA-stimulated transcription, yet is not required for re- 
pression of SRE-dependent transcription by SRF. Therefore, 
the core region of SRF is most likely required and sufficient for 
the SRE-dependent repression of transcription. 
We speculated that the function of the N-terminus was ob- 
structed in the presence of the C-terminus. Thus, we con- 
structed the N-terminal truncations AN2 and AN4 in the con- 
text of AC9 (Fig. 3A). Consistent with a partial loss of the 
N-terminal repression domain, the respective mutant AN2/AC9 
displayed a 2-fold higher level of relative luciferase activity with 
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Fig. 1. SRF-mediated repression of transcription. The SRE2-tk80-1uc reporter plasmid (A) or the SRE-less tk80-1uc reporter plasmid (B) were 
co-transfected with different amounts of either the SG-SRF expression plasmid or the parental vector SG-new. Transfected NIH 3T3 cells were then 
kept in medium containing 10% fetal calf serum for 36 h. Luciferase activity of cells transfected with solely tk80-1uc was arbitrarily set to 100%. 
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Fig. 2. Effects of TBP on transcription. The SRE2-tk80-1uc (A) or the tk80-1uc reporter plasmid (B) were co-transfected with increasing amounts of 
human TBP expression plasmid and either 1.5/lg SG-SRF expression plasmid or 1.5 pg of the parental vector SG-new. Luciferase activity derived 
from NIH 3T3 cells transfected with the expression vector SG-new in the absence of TBP was arbitrarily set to 100%. 
the SRE2-tk80-1uc reporter compared to AC9, which was not 
observed with the tk80-1uc reporter (Fig. 3B). Thus, the 
N-terminal repression domain of SRF contributes to SRE- 
specific transcriptional repression mediated by/IC9. Although 
the N-terminal repression domain is apparently functionally 
impeded by the C-terminus in full-length SRF, conformational 
changes within SRF could alter this situation at binding sites 
other than the c-Jbs SRE or upon interaction with different 
affiliated proteins. Precedent for such a mechanism is provided 
by the yeast protein MCM 1, which shares with SRF a homol- 
ogous core region. MCM1 undergoes conformational changes 
at selected promoter sites and thereby exposes a previously 
shielded transactivation domain [22]. Further deleting parts of 
the N-terminal repression domain in AN4/AC9 drastically in- 
creased relative luciferase activity from both the SRE2-tk80-1uc 
and the tk80-1uc reporter (Fig. 3A,B), indicating that these 
effects were binding-site unspecific. 
We questioned whether phosphorylation was involved in the 
effects on binding site independent transcription mediated by 
the N-terminus. For this purpose, the four potential casein 
kinase II sites S 77, S 79, S 83 and S 85 [15,16,23] were mutated to 
alanine in the M4/AC9 mutant (Fig. 3A). Both SRE-driven and 
SRE-independent relative luciferase levels were elevated in 
comparison to AC9 (Fig. 3B), indicating that this effect is not 
SRE-specific. Further mutating the phosphoacceptor S ~°3 
[15,18] to alanine in the mutant M9/AC9 had no additional 
effect. The M6/AC9 mutant, differing from AC9 only by the 
mutation of S ~°3 to alanine, displayed a phenotype comparable 
to AC9. Thus, the presence of S 1°3 does not affect SRE-inde- 
pendent ranscription. Taken together, these results demon- 
strate that the presence of the potential casein kinase II sites 
in the region 77 85 influences AC9's impact on SRE-independ- 
ent transcription. 
Introducing the M4-, M6- or M9-mutations into the context 
of full-length CMV-SRF paralleled the trends observed with 
the corresponding AC9 mutants, although the effects were 
much less pronounced (Fig. 3A,B). This again implies that the 
presence of the C-terminus of SRF impedes the function of the 
N-terminal domain. Finally, mutation of the phosphorylation 
sites did not significantly affect the ability to mediate TPA 
induction, since the M4, M6 and M9 mutants were comparable 
to CMV-SRF and the M4/AC9, M6/AC9 and M9/AC9 mutants 
resembled the respective AC9 molecule (Fig. 3C). 
4. Discussion 
Although it has been shown that basal repression of the c-[bs 
gene is dependent on a functional SRE [2-4], none of the many 
SRE-binding proteins [1] has been demonstrated to mediate 
c-fos repression. Our results how that over-expressed SRF can 
repress SRE-dependent transcription i NIH 3T3 cells. Neither 
the N-terminal repression domain nor the C-terminal transacti- 
vation domain were required for this function. Endogenous 
SRF is also 'over-expressed' after serum stimulation with a 
delayed kinetics relative to c-Jos [5,24]. Thereby endogenous 
SRF may contribute to post-induction repression of cofos, pos- 
sibly by sequestering a co-activator required for SRE-mediated 
transcription. Two lines of evidence argue for such an indirect 
mechanism: (i) introduction of two c-[bs SREs into tk80-1uc led 
to an approximately 3-fold enhanced level of luciferase activity 
in the absence of any exogenous SRF (see Fig. 1), indicating 
that the SRE, and thus very likely its binding protein SRF, 
actually activates transcription. Since even small doses of ex- 
ogenous SRF led to a reduction of transcription, this would 
imply that the concentration of endogenous SRF in NIH 3T3 
cells is close to, or already in, the squelching region of 
its dose-response curve. (ii) Over-expression f TBP, which re- 
sults in squelching of TATA-box mediated transcription i the 
presence and absence of over-expressed SRF, squelched 
SRE-dependent transcription only in the absence of exogenous 
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Fig. 3. Transcriptional activity of SRF truncations and phosphorylation mutants. (A) Schematic presentation f SRF molecules utilized. The positions 
of serine-to-alanine exchanges are indicated. (B) 1.5/lg of the indicated expression plasmid was co-transfected with SRE2-tk80-1uc (stippled bars) 
or tk80-1uc (white bars) into NIH 3T3 cells that were kept in medium containing 10% fetal calf serum for 36 h after transfection. Luciferase activity 
obtained from cells transfected with the empty expression vector pEV3S and the tk80-1uc reporter construct was set to 100%. (C) Starved NIH 3T3 
cells, which had been transfected with 1.5 pg of the indicated expression plasmid and with the SREz-tk80-1uc reporter plasmid, were induced for 
3 h with TPA. The enhancement of luciferase activity over starved cells is depicted. 
SRF. This strongly suggests that exogenous SRF already se- 
questers a co-activator indispensable for SRE-dependent tran- 
scription. This co-activator does not appear to be TBP itself, 
since exogenous TBP could not alleviate the SRF-mediated 
repression of SRE-driven transcription and similarly ex- 
ogenous SRF did not inhibit TBP-mediated squelching observ- 
able with the tk80-1uc reporter. The latter fact also argues 
against he possibility that this co-activator is a general tran- 
scription factor such as TFIIF, with which SRF reportedly 
interacts [25]. 
The sequestration f a co-activator by SRF could also affect 
promoters without SRF binding sites if other transcription 
factors rely on the same co-activator for function. Indeed, 
squelching of such a common co-activator has been described 
for SRF in in vitro transcription assays [26]. Thereby, SRF may 
pleiotropically influence the transcriptional status of a cell. 
Such a scenario f regulatory squelching may be widespread 
[27] and could also explain how the Fos protein represses its 
own expression via the SRE, independently of its own DNA- 
binding domain [28-30]. It is even conceivable that both SRF 
and Fos sequester the same co-activator and thus jointly affect 
c-fos down-regulation after c-fos induction. 
SRF may additionally affect he general transcriptional pro- 
file of a cell by virtue of its casein kinase II target sites S 77, S 79, 
S 83 and S 85 [15,16,23]. Mutating these in vivo phosphorylation 
sites to alanine in the context of the AC9 protein raised the levels 
of luciferase activity SRE-independently. Presently, we cannot 
definitively explain this phenomenon, yet these alanine mutants 
may sequester a co-activator the high abundance of which 
normally induces ome type of squelching. Alternatively, these 
alanine mutants may recruit a transcriptional repressor. Since 
AN4/AC9, which nearly matches the DNA-binding core region, 
also displayed such a phenotype, it is proposed that the core 
region interacts with this hypothetical co-activator  repressor 
and that this interaction is prevented by the phosphorylation 
of the casein kinase II sites within the N-terminus. We note that 
this interaction partner would not be the co-activator seques- 
tered by full-length SRF in Fig. 1, since there the SRE-inde- 
pendent transcription was unaffected by SRF. The effects on 
SRE-independent transcription upon mutating the casein ki- 
nase II sites at S 77, S 79, S 83 and S +5 were much less pronounced 
yet also measurable with the full-length SRF molecule, suggest- 
ing that the N-terminus i functionally impeded in the presence 
of the C-terminus. Irrespective of the mechanism involved, our 
data show for the first time the modulation of transcription by 
the SRF casein kinase II sites in the region 77 85 in an SRE- 
independent fashion. 
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